GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orphazyme AS (OCSE:ORPHA) » Definitions » Cash from Discontinued Operating Activities

Orphazyme AS (OCSE:ORPHA) Cash from Discontinued Operating Activities : kr0.00 Mil (TTM As of Jun. 2022)


View and export this data going back to 2017. Start your Free Trial

What is Orphazyme AS Cash from Discontinued Operating Activities?

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Orphazyme AS's Cash from Discontinued Operating Activities for the six months ended in Jun. 2022 was kr0.00 Mil. It means Orphazyme AS received kr0.00 Mil from discontinued investing activities. Orphazyme AS's Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Jun. 2022 was kr0.00 Mil.

Orphazyme AS Cash from Discontinued Operating Activities Historical Data

The historical data trend for Orphazyme AS's Cash from Discontinued Operating Activities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orphazyme AS Cash from Discontinued Operating Activities Chart

Orphazyme AS Annual Data
Trend Jun14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Cash from Discontinued Operating Activities
Get a 7-Day Free Trial - - - - -

Orphazyme AS Semi-Annual Data
Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22
Cash from Discontinued Operating Activities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Orphazyme AS Cash from Discontinued Operating Activities Calculation

Cash from Discontinued Operating Activities is net cash from all of the entity's discontinued operating activities.

Cash from Discontinued Operating Activities for the trailing twelve months (TTM) ended in Jun. 2022 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Orphazyme AS Cash from Discontinued Operating Activities Related Terms

Thank you for viewing the detailed overview of Orphazyme AS's Cash from Discontinued Operating Activities provided by GuruFocus.com. Please click on the following links to see related term pages.

Orphazyme AS (OCSE:ORPHA) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Orphazyme AS (OCSE:ORPHA) » Definitions » Cash from Discontinued Operating Activities
Comparable Companies
SGX:5DO SGX:5KI SGX:DRX SGX:533 SGX:5OI OCSE:NOVO B ASX:CSL REGN VRTX MRNA XKRX:207940 BNTX HKSE:02269 SGEN SZSE:300122 SHSE:603392 OCSE:GMAB RPRX INCY XBRU:ARGX
Traded in Other Exchanges
N/A
Address
Ole Maaloes Vej 3, Copenhagen, DNK, DK-2200
Website
https://www.orphazyme.com
Orphazyme AS is a late-stage biopharmaceutical company engaged in the development and commercialization of novel therapeutics for the treatment of neurodegenerative rare diseases. The company's lead candidate, Arimoclomol, is in development for severe orphan diseases: Niemann-Pick disease Type C (NPC), Amyotrophic Lateral Sclerosis (ALS), and Inclusion Body Myositis (IBM).

Orphazyme AS (OCSE:ORPHA) Headlines

No Headlines